Why is Sudeep Pharma Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 18.30% and Operating profit at 9.53% over the last 5 years
2
Flat results in Sep 26
- INTEREST(Q) Highest at Rs 2.81 cr
3
With ROE of 19.7, it has a Very Expensive valuation with a 14 Price to Book Value
4
Majority shareholders : Promoters
How much should you hold?
- Overall Portfolio exposure to Sudeep Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
18.30%
EBIT Growth (5y)
9.53%
EBIT to Interest (avg)
26.52
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.63
Tax Ratio
24.48%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.98%
ROCE (avg)
23.92%
ROE (avg)
19.67%
Valuation Key Factors 
Factor
Value
P/E Ratio
71
Industry P/E
40
Price to Book Value
14.04
EV to EBIT
57.86
EV to EBITDA
53.91
EV to Capital Employed
13.10
EV to Sales
19.04
PEG Ratio
NA
Dividend Yield
0.13%
ROCE (Latest)
22.64%
ROE (Latest)
19.67%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Movement
12What is working for the Company
NET SALES(Q)
Highest at Rs 196.70 cr
PBDIT(Q)
Highest at Rs 73.24 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 37.23%
PBT LESS OI(Q)
Highest at Rs 65.05 cr.
PAT(Q)
Highest at Rs 51.45 cr.
-10What is not working for the Company
INTEREST(Q)
Highest at Rs 2.81 cr
Loading Valuation Snapshot...
Here's what is working for Sudeep Pharma
Net Sales - Quarterly
Highest at Rs 196.70 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 73.24 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 37.23%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 65.05 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 65.05 cr has Grown at 24.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 52.35 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 51.45 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Sudeep Pharma
Interest - Quarterly
At Rs 2.81 cr has Grown at 36.41%
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Interest - Quarterly
Highest at Rs 2.81 cr
in the last five quarters and Increased by 36.41 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)